United States Securities and Exchange Commission · EDGAR Accession 0002068932-26-000001

Form C-AR

Annual Report — Regulation Crowdfunding
Issuer CIK 2068932
Period 2025-12-31

Bala Enzyme Inc.

CorporationDEIncorporated 2021Seal Beach, CAbalaenzyme.com
B

Financial Condition

two fiscal years, as filed
Revenue −8% YoYBurn increasingDebt / assets 112%2 employees
Line itemMost recent FYPrior FYΔ
Revenue312,983339,970▼ 8%
Cost of goods sold149,928140,539▲ 7%
Net income(373,545)(372,370)▼ burn
Total assets398,145126,719▲ 214%
Cash & equivalents241,0522,643
Accounts receivable(835)12,048
Short-term debt240,785305,943▼ 21%
Long-term debt205,536418,573▼ 51%
Taxes paid00

Figures in USD as reported by the issuer.